Rory B. Riggs, Director at Intra-Cellular Therapies, Inc. (ITCI), sold 453,340 shares at $58.72 ($27.2M) on 2022-03-16, disclosed to the SEC on 2022-03-18.
Open-market sale of $27.2M ITCI by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $58.72 | 20,686 | $1.2M | 4.5% |
| 2 | $58.72 | 20,686 | $1.2M | 4.5% |
| 3 | $59.53 | 43,848 | $2.6M | 9.6% |
| 4 | $59.53 | 43,848 | $2.6M | 9.6% |
| 5 | $59.99 | 26,587 | $1.6M | 5.9% |
| 6 | $59.99 | 26,587 |
| $1.6M |
| 5.9% |
| 7 | $60.41 | 114,912 | $6.9M | 25.5% |
| 8 | $60.41 | 114,912 | $6.9M | 25.5% |
| 9 | $60.63 | 4,901 | $297K | 1.1% |
| 10 | $60.63 | 4,901 | $297K | 1.1% |
| 11 | $61.35 | 15,736 | $965K | 3.5% |
| 12 | $61.35 | 15,736 | $965K | 3.5% |
| Total | $60.11 avg | 453,340 | $27.2M | 100% |
| Filing → |
| CBUS | BUY | 2023-12-14 | $10.9M | — | Filing → |
| CBUS | BUY | 2023-06-02 | $32K | — | Filing → |
| RPRX | SELL | 2023-05-22 | $57.4M | — | Filing → |